Brief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Yesterday 12:58
BRIEF-Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder June 29 (Reuters) - Brainsway Ltd BWAY.TA:
BRAINSWAY PRESENTS POSITIVE DATA FROM LARGEST REAL-WORLD STUDY OF DEEP TMS™ IN PATIENTS WITH COMORBID PTSD AND MAJOR DEPRESSIVE DISORDER
BRAINSWAY - 83.5% OF COMORBID PTSD AND MDD PATIENTS RESPOND TO DEEP TMS WITH 52% MEAN PTSD SYMPTOM REDUCTION
Source text: ID:nGNX3GnrNS
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)